STK11 p.F354L Germline Mutation in a Case of Multiple Gastrointestinal Tumors

Yohei Kojima1, Kouki Ohtsuka2, Shun Ishii1

  • 1Department of Gastroenterological and General Surgery, Kyorin University Faculty of Medicine, Tokyo, Japan.

Insights

This study reports the first case of a germline mutation in the STK11 gene (p.F354L) found in a patient with multiple gastrointestinal tumors. This finding suggests a potential link between STK11 germline mutations and sporadic gastrointestinal cancers.

Area of Science:

  • Oncology
  • Genetics
  • Gastroenterology

Background:

  • Serine/threonine kinase 11 (STK11) is a crucial tumor suppressor gene frequently altered in various human cancers.
  • The STK11 p.F354L mutation has been previously observed in sporadic colon and lung cancer cases.

Observation:

  • A 75-year-old male presented with multiple gastrointestinal tumors, including duodenal adenoma, gastric adenoma, rectal adenocarcinoma, and liver metastasis.
  • Next-generation sequencing revealed the STK11 p.F354L mutation in all tumor samples and normal rectal mucosa.
  • No hamartomatous polyps characteristic of Peutz-Jeghers syndrome were found.

Findings:

  • The study identified the STK11 p.F354L mutation as a germline mutation present in all examined tissues, including normal mucosa.
  • Somatic mutations, including KRAS p.A146T, TP53, and APC, were found in tumor samples.
  • This represents the first documented instance of an STK11 germline mutation in a patient with multiple gastrointestinal tumors.

Implications:

  • This case highlights the potential role of STK11 germline mutations in the development of sporadic gastrointestinal cancers.
  • Further research is warranted to explore the prevalence and clinical significance of STK11 germline mutations in gastrointestinal oncology.
  • Understanding these genetic underpinnings may lead to novel diagnostic and therapeutic strategies.